BOSTON & DAEJEON, South Korea, October 15, 2025--(BUSINESS WIRE)--Orum Therapeutics ("Orum" or the "Company") (KRX: 475830), a public biotechnology company pioneering the field of degrader-antibody ...
Romania’s justice minister offered his resignation Thursday after failing to put forward a controversial measure pushed by the ruling party — but which Brussels warned would violate EU rule of law ...
Orum Therapeutics Appoints Dr. Dorin Toader as Head of Platform Technology to Advance Orum’s Degrader–Antibody Conjugate Payload Platforms and Expand TPD²® Therapeutic Applications Orum Therapeutics ( ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results